Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Conditions:   Dyslipidemias;   Atherosclerosis;   Diabetes Mellitus, Type 2 Interventions:   Drug: Omega 3-Atorvastatin;   Drug: Atorvastatin-Ezetimibe Sponsors:   Seoul National University Bundang Hospital;   Korea United Pharm. Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2022 Category: Research Source Type: clinical trials

Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
Condition:   Abortion Early Interventions:   Drug: Atorvastatin;   Drug: Misoprostol Sponsors:   University of Utah;   Grand Challenges Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2022 Category: Research Source Type: clinical trials